BBGBloomberg·3hBusiness
score+0.70
Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO
Original
Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO
“Strong positive framing emphasizing successful fundraising milestone, investor confidence, and favorable pricing terms.”